Tabunda, Argie, Jr. N.

HRN: 27-13-70  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/01/2025
CEFUROXIME 750MG (VIAL)
07/01/2025
07/08/2025
IV
650mg
Q8h
UTI
Waiting Final Action 
07/04/2025
CEFTRIAXONE 1G (VIAL)
07/04/2025
07/11/2025
IVT
1g
Q12
T/C Typhoid Fever
Remove - Pending Acceptance
07/05/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
07/05/2025
07/12/2025
PO
8ml
TID
Infectious Diarrhea
Waiting Final Action 
07/08/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/08/2025
07/15/2025
IV
975mg
Q6h
Typhoid Fever; UTI
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: